New depression pill shows promise in early trial
NCT ID NCT04103892
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 29 times
Summary
This study tested a new drug called CLE-100 in 146 adults with major depressive disorder who were already taking standard antidepressants. The goal was to see if adding CLE-100 could further reduce depression symptoms. Participants were randomly assigned to receive either CLE-100 or a placebo, and their depression severity was measured using a standard rating scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site 101
Marlton, New Jersey, 08053, United States
-
Clinical Site 102
Staten Island, New York, 10312, United States
-
Clinical Site 103
Boston, Massachusetts, 02114, United States
-
Clinical Site 104
Decatur, Georgia, 30030, United States
-
Clinical Site 105
Orlando, Florida, 32803, United States
-
Clinical Site 106
Media, Pennsylvania, 19063, United States
-
Clinical Site 107
Hialeah, Florida, 33016, United States
-
Clinical Site 108
Miami Gardens, Florida, 33014, United States
-
Clinical Site 109
Houston, Texas, 77030, United States
-
Clinical Site 110
Las Vegas, Nevada, 89102, United States
-
Clinical Site 111
Hickory, North Carolina, 28601, United States
-
Clinical Site 112
Torrance, California, 90502, United States
-
Clinical Site 113
Oceanside, California, 92056, United States
-
Clinical Site 114
Fort Worth, Texas, 76104, United States
-
Clinical Site 115
Bellflower, California, 90706, United States
-
Clinical Site 116
Miami, Florida, 33145, United States
-
Clinical Site 117
Oakland, California, 94607, United States
-
Clinical Site 118
Philadelphia, Pennsylvania, 19104, United States
-
Clinical Site 120
Little Rock, Arkansas, 72209, United States
-
Clinical Site 121
Boston, Massachusetts, 02131, United States
-
Clinical Site 122
Marietta, Georgia, 30060, United States
-
Clinical Site 123
Riverside, California, 92506, United States
-
Clinical Site 124
Santa Ana, California, 92705, United States
-
Clinical Site 125
Lincoln, Nebraska, 68526, United States
-
Clinical Site 126
Bentonville, Arkansas, 72712, United States
-
Clinical Site 127
North Canton, Ohio, 44720, United States
-
Clinical Site 128
New York, New York, 10036, United States
-
Clinical Site 129
Little Rock, Arkansas, 72209, United States
-
Clinical Site 131
Baltimore, Maryland, 21208, United States
-
Clinical Site 132
Lafayette, California, 94549, United States
-
Clinical Site 135
Bellevue, Washington, 98007, United States
-
Clinical Site 136
Rockville, Maryland, 20877, United States
-
Clinical Site 137
Orlando, Florida, 32807, United States
-
Clinical Site 138
Middleburg Heights, Ohio, 44130, United States
-
Clinical Site 139
St Louis, Missouri, 63128, United States
-
Clinical Site 140
Atlanta, Georgia, 30338, United States
-
Clinical Site 141
Anaheim, California, 92805, United States
-
Clinical Site 142
Santa Rosa, California, 95401, United States
-
Clinical Site 143
Raleigh, North Carolina, 27609, United States
-
Clinical Site 144
Plano, Texas, 75093, United States
-
Clinical Site 145
Denver, Colorado, 80209, United States
-
Clinical Site 147
Draper, Utah, 84020, United States
-
Clinical Site 148
Toms River, New Jersey, 08755, United States
-
Clinical Site 149
Missouri City, Texas, 88459, United States
-
Clinical Site 150
San Juan, 00918, Puerto Rico
-
Clinical Site 151
Dearborn Heights, Michigan, 48034, United States
Conditions
Explore the condition pages connected to this study.